Eckert & Ziegler SE

XTRA:EUZ Voorraadrapport

Marktkapitalisatie: €943.0m

Eckert & Ziegler Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Harald Hasselmann

Algemeen directeur

€475.2k

Totale compensatie

Percentage CEO-salaris65.7%
Dienstverband CEO7.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn4.8yrs
Gemiddelde ambtstermijn bestuur5.7yrs

Recente managementupdates

Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All

Jun 20
Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All

Recent updates

Eckert & Ziegler SE's (ETR:EUZ) Share Price Could Signal Some Risk

Aug 08
Eckert & Ziegler SE's (ETR:EUZ) Share Price Could Signal Some Risk

Does Eckert & Ziegler (ETR:EUZ) Have A Healthy Balance Sheet?

Jul 17
Does Eckert & Ziegler (ETR:EUZ) Have A Healthy Balance Sheet?

Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All

Jun 20
Why We Think Eckert & Ziegler SE's (ETR:EUZ) CEO Compensation Is Not Excessive At All

Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)

Jun 05
Investors Met With Slowing Returns on Capital At Eckert & Ziegler (ETR:EUZ)

Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?

May 13
Is Now An Opportune Moment To Examine Eckert & Ziegler SE (ETR:EUZ)?

Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected

Apr 27
Eckert & Ziegler SE (ETR:EUZ) Investors Are Less Pessimistic Than Expected

Here's Why Eckert & Ziegler (ETR:EUZ) Can Manage Its Debt Responsibly

Apr 12
Here's Why Eckert & Ziegler (ETR:EUZ) Can Manage Its Debt Responsibly

Slowing Rates Of Return At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Leave Little Room For Excitement

Mar 06
Slowing Rates Of Return At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Leave Little Room For Excitement

What Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) P/E Is Not Telling You

Jan 04
What Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) P/E Is Not Telling You

Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has A Pretty Healthy Balance Sheet

Dec 20
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has A Pretty Healthy Balance Sheet

Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Hasn't Managed To Accelerate Its Returns

Nov 15
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Hasn't Managed To Accelerate Its Returns

What Is Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Share Price Doing?

Oct 01
What Is Eckert & Ziegler Strahlen- und Medizintechnik AG's (ETR:EUZ) Share Price Doing?

A Look At The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)

Aug 22
A Look At The Intrinsic Value Of Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)

These 4 Measures Indicate That Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Using Debt Reasonably Well

Jul 16
These 4 Measures Indicate That Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is Using Debt Reasonably Well

Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Jun 22
Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

The Return Trends At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Look Promising

May 17
The Return Trends At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Look Promising

Is Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ) Potentially Undervalued?

Mar 20
Is Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ) Potentially Undervalued?

Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns Have Hit A Wall

Jan 24
Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns Have Hit A Wall

We Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Can Stay On Top Of Its Debt

Oct 27
We Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Can Stay On Top Of Its Debt

Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Oct 05
Is It Time To Consider Buying Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has Some Way To Go To Become A Multi-Bagger

Aug 21
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Has Some Way To Go To Become A Multi-Bagger

Is Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) A Risky Investment?

Jul 21
Is Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) A Risky Investment?

Is There Now An Opportunity In Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Jun 13
Is There Now An Opportunity In Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Will Pay A Larger Dividend Than Last Year At €0.50

May 13
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Will Pay A Larger Dividend Than Last Year At €0.50

Returns At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Are On The Way Up

May 09
Returns At Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Are On The Way Up

Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50

Apr 24
Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50

Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50

Mar 27
Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Dividend Will Be Increased To €0.50

Do Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Earnings Warrant Your Attention?

Mar 25
Do Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Earnings Warrant Your Attention?

When Should You Buy Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Feb 17
When Should You Buy Eckert & Ziegler Strahlen- und Medizintechnik AG (ETR:EUZ)?

Investors Will Want Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Growth In ROCE To Persist

Jan 31
Investors Will Want Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Growth In ROCE To Persist

Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today

Dec 13
Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today

Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns On Capital Are Heading Higher

Nov 01
Eckert & Ziegler Strahlen- und Medizintechnik's (ETR:EUZ) Returns On Capital Are Heading Higher

Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today

Sep 14
Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Deserve Your Attention Today

Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Have The Makings Of A Multi-Bagger

Jul 29
Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Might Have The Makings Of A Multi-Bagger

Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is An Interesting Stock

Jun 11
Here's Why I Think Eckert & Ziegler Strahlen- und Medizintechnik (ETR:EUZ) Is An Interesting Stock

Analyse CEO-vergoeding

Hoe is Harald Hasselmann's beloning veranderd ten opzichte van Eckert & Ziegler's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

€36m

Jun 30 2024n/an/a

€38m

Mar 31 2024n/an/a

€34m

Dec 31 2023€475k€312k

€30m

Sep 30 2023n/an/a

€33m

Jun 30 2023n/an/a

€29m

Mar 31 2023n/an/a

€30m

Dec 31 2022€543k€250k

€31m

Sep 30 2022n/an/a

€27m

Jun 30 2022n/an/a

€27m

Mar 31 2022n/an/a

€27m

Dec 31 2021€509k€216k

€35m

Sep 30 2021n/an/a

€33m

Jun 30 2021n/an/a

€31m

Mar 31 2021n/an/a

€30m

Dec 31 2020€400k€209k

€21m

Sep 30 2020n/an/a

€21m

Jun 30 2020n/an/a

€22m

Mar 31 2020n/an/a

€21m

Dec 31 2019€366k€204k

€22m

Sep 30 2019n/an/a

€22m

Jun 30 2019n/an/a

€21m

Mar 31 2019n/an/a

€20m

Dec 31 2018€347k€196k

€16m

Sep 30 2018n/an/a

€16m

Jun 30 2018n/an/a

€14m

Mar 31 2018n/an/a

€11m

Dec 31 2017€345k€189k

€12m

Compensatie versus markt: De totale vergoeding ($USD 501.49K ) Harald } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 1.42M ).

Compensatie versus inkomsten: De vergoeding van Harald is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Harald Hasselmann (57 yo)

7.8yrs

Tenure

€475,161

Compensatie

Dr. Harald Hasselmann was Deputy Chairman of the Supervisory Board of Pentixapharm Holding AG from February 15, 2024 until 2024. Dr. Hasselmann is Chairman of the Executive Board of Medical Segment at Ecke...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Harald Hasselmann
CEO & Chairman of the Executive Board of Medical Segment7.8yrs€475.16kgeen gegevens
Franklin Yeager
President of Eckert and Ziegler Isotope Products Inc. & Member of Executive Board1.4yrs€1.12mgeen gegevens
Jutta Ludwig
Member of Executive Board of Asia Business1.8yrs€181.48kgeen gegevens
Gunnar Mann
Head of Intragroup Services12.8yrsgeen gegevensgeen gegevens
Ana Ramirez
Head of Segment Isotope Productsless than a yeargeen gegevensgeen gegevens
Ivan Simmer
Managing Director of Eckert & Ziegler Cesio s.r.o.10.8yrsgeen gegevensgeen gegevens
Joseph Hathcock
Vice President of Eckert & Ziegler Isotope Products Inc.no datageen gegevensgeen gegevens

4.8yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van EUZ wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Andreas Eckert
Chairman of the Supervisory Boardless than a year€700.71k0.000020%
€ 188.6
Frank Perschmann
Member of Supervisory Board5.5yrs€37.92kgeen gegevens
Edgar Löffler
Member of Supervisory Board5.8yrs€34.58kgeen gegevens
Helmut Grothe
Deputy Chairman of the Supervisory Board10.3yrs€39.00kgeen gegevens
Paola Eckert-Palvarini
Member of Supervisory Board1.9yrsgeen gegevensgeen gegevens
Albert Rupprecht
Member of Supervisory Board7.5yrs€37.67kgeen gegevens

5.7yrs

Gemiddelde duur

67.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van EUZ wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.7 jaar).